GlassScriptPhysician profile
John T Archer
NPI 1568565034
$1,963.48
in general payments reported to CMS, 2019-2025
18 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.39 · 2020: $88.25 · 2021: $238 · 2022: $241 · 2023: $412 · 2024: $532 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $650.03 | 2022-2025 | Infuse, Vyzulta, Miebo |
| Alcon Vision LLC | $254.62 | 2022-2025 | Precision 1, Tryptyr, Rocklatan |
| Dompe US, INC. | $154.89 | 2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $104.36 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $103.69 | 2021 | |
| Coopervision INC. | $96.55 | 2021-2024 | Myday Contact Lens |
| Abbvie INC. | $83.19 | 2022-2023 | Vuity, Lumigan, Alphagan P |
| Novartis Pharmaceuticals Corporation | $73.76 | 2021-2023 | |
| Tarsus Pharmaceuticals, INC. | $73.16 | 2024-2025 | Xdemvy |
| Synergeyes, INC. | $67.00 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $64.88 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $61.73 | 2020-2022 | |
| Biotissue Holdings INC. | $50.00 | 2024 | |
| Oyster Point Pharma, INC. | $42.07 | 2024-2025 | Tyrvaya, Ryzumvi |
| Allergan, INC. | $33.96 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $32.54 | 2024-2025 | Acthar |
| Shire North American Group INC | $12.33 | 2019 | |
| Abb Con-Cise Optical Group LLC | $4.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Archer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.